Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03851328
Other study ID # 2017-00575; qu17Gut
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2017
Est. completion date December 30, 2019

Study information

Verified date May 2020
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This pilot project investigates the use of a structured medication history (Best Possible Medication History, BPMH) in patients (primarily admitted at the emergency department of University Hospital Basel) after transfer to a medical ward. Unintentional medication discrepancies are analyzed comparing outpatient and inpatient medication therapy.


Recruitment information / eligibility

Status Completed
Enrollment 160
Est. completion date December 30, 2019
Est. primary completion date October 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Admission to Emergency Department of University Hospital Basel and transfer to medical ward

Exclusion Criteria:

- medication history taken at Emergency Department of University Hospital Basel not present

Study Design


Related Conditions & MeSH terms


Intervention

Other:
BPMH structured interview
creating a standardized medication list by interviewing patient and/ or relatives according to Best Possible Medication History (BPMH) after patient transfer to medical ward

Locations

Country Name City State
Switzerland Spitalpharmazie Universitätsspital Basel (USB) Basel

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary unintended medication discrepancy number of unintended medication discrepancies comparing medication history taken when admitted to emergency department and BPMH after transfer to medical ward single time point (1 day after admission to hospital)
Secondary Categorisation ( Class1, Class2, Class3) for clinical relevance of unintended medication discrepancy expert panel classifies each unintended medication discrepancy in 1 of 3 classes for its potential to cause patient harm. Class 1 discrepancies are those unlikely to cause patient discomfort or clinical deterioration. Class 2 discrepancies could potentially result in moderate discomfort or clinical deterioration. Class 3 discrepancies could potentially result in severe discomfort or clinical deterioration. during 7 days after admission to hospital